Skip to main content
. Author manuscript; available in PMC: 2015 Dec 1.
Published in final edited form as: Cancer Chemother Pharmacol. 2014 Sep 26;74(6):1191–1198. doi: 10.1007/s00280-014-2593-7

Figure 1.

Figure 1

Metaiodobenzylguanidine (MIBG, top panels) and Single Photon Emission Computed Tomography (SPECT, bottom panels) of a patient with metastatic neuroblastoma (arrows) showing complete response after 10 weeks of therapy with oral irinotecan and gefitinib.